105219-33-8

Basic information

• Product Name: Carbamodithioic acid, [(4-methoxyphenyl)methyl]-, methyl ester
• CAS NO: 105219-33-8
• Molecular Formula: C10H13NOS2
• Molecular Weight: 227.351
• Mol File: 105219-33-8.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Carbamodithioic acid, [(4-methoxyphenyl)methyl]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamodithioic acid, [(4-methoxyphenyl)methyl]-, methyl ester(105219-33-8)
• EPA Substance Registry System: Carbamodithioic acid, [(4-methoxyphenyl)methyl]-, methyl ester(105219-33-8)

Safety Data

• Hazardous Substances Data: 105219-33-8(Hazardous Substances Data)

Upstream product

• 2393-23-9 4-methoxy-benzylamine 
• 74-88-4 methyl iodide 
• 75-15-0 carbon disulfide 

Downstream Products

• 16735-76-5 N-(4-methoxybenzyl)hydrazinecarbothioamide 

Relevant articles and documents

Synthesis, crystal structure, molecular docking studies and bio-evaluation of some N4-benzyl-substituted isatin-3-thiosemicarbazones as urease and glycation inhibitors

Fifteen N4-benzyl-substituted isatin-3-thiosemicarbazones 5a-o were synthesized and evaluated for their urease and glycation inhibitory potential. Lemna aequinocitalis growth and Artemia salina assays were also done to determine their phytotoxi

HINDERED DISULFIDE DRUG CONJUGATES

The invention relates generally to disulfide drug conjugates wherein a linker comprising a sulfur-bearing carbon atom substituted with at least one hydrocarbyl or substituted hydrocarbyl is conjugated by a disulfide bond to a cysteine sulfur atom of a targeting carrier, and wherein the linker is further conjugated to a drug moiety. The invention further relates to activated linker-drug conjugates suitable for conjugation to a targeting carrier by a disulfide bond. The invention further relates to methods for preparing hindered disulfide drug conjugates.

SURFUR-CONTAINING ALKALOIDS WITH ANTI-INFLAMMATORY ACTIVITY AND METHOD OF SYNTHESIS

The extract from Bretschneidera sinensis, surfur-containing alkaloids disclosed in the present aspects have characterized by presented pharmaceutics, cosmetics and foods having functions to improve anti-inflammatory activity.